Global Cell therapy Processing Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cell therapy Processing Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Products
  • 1.4.3 Services
  • 1.4.4 Software
• 1.5 Market by Application
  • 1.5.1 Global Cell therapy Processing Market Share by Application (2014-2025)
  • 1.5.2 Cardiovascular Disease
  • 1.5.3 Bone Repair
  • 1.5.4 Neurological Disorders
  • 1.5.5 Skeletal Muscle RepairImmune Diseases
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Cell therapy Processing Market Size
• 2.2 Cell therapy Processing Growth Trends by Regions
  • 2.2.1 Cell therapy Processing Market Size by Regions (2014-2025)
  • 2.2.2 Cell therapy Processing Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Cell therapy Processing Market Size by Manufacturers
  • 3.1.1 Global Cell therapy Processing Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Cell therapy Processing Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
• 3.2 Cell therapy Processing Key Players Head office and Area Served
• 3.3 Key Players Cell therapy Processing Product/Solution/Service
• 3.4 Date of Enter into Cell therapy Processing Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Cell therapy Processing Market Size by Type (2014-2019)
• 4.2 Global Cell therapy Processing Market Size by Application (2014-2019)

5 United States

• 5.1 United States Cell therapy Processing Market Size (2014-2019)
• 5.2 Cell therapy Processing Key Players in United States
• 5.3 United States Cell therapy Processing Market Size by Type
• 5.4 United States Cell therapy Processing Market Size by Application

6 Europe

• 6.1 Europe Cell therapy Processing Market Size (2014-2019)
• 6.2 Cell therapy Processing Key Players in Europe
• 6.3 Europe Cell therapy Processing Market Size by Type
• 6.4 Europe Cell therapy Processing Market Size by Application

7 China

• 7.1 China Cell therapy Processing Market Size (2014-2019)
• 7.2 Cell therapy Processing Key Players in China
• 7.3 China Cell therapy Processing Market Size by Type
• 7.4 China Cell therapy Processing Market Size by Application

8 Japan

• 8.1 Japan Cell therapy Processing Market Size (2014-2019)
• 8.2 Cell therapy Processing Key Players in Japan
• 8.3 Japan Cell therapy Processing Market Size by Type
• 8.4 Japan Cell therapy Processing Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Cell therapy Processing Market Size (2014-2019)
• 9.2 Cell therapy Processing Key Players in Southeast Asia
• 9.3 Southeast Asia Cell therapy Processing Market Size by Type
• 9.4 Southeast Asia Cell therapy Processing Market Size by Application

10 India

• 10.1 India Cell therapy Processing Market Size (2014-2019)
• 10.2 Cell therapy Processing Key Players in India
• 10.3 India Cell therapy Processing Market Size by Type
• 10.4 India Cell therapy Processing Market Size by Application

11 Central & South America

• 11.1 Central & South America Cell therapy Processing Market Size (2014-2019)
• 11.2 Cell therapy Processing Key Players in Central & South America
• 11.3 Central & South America Cell therapy Processing Market Size by Type
• 11.4 Central & South America Cell therapy Processing Market Size by Application

12 International Players Profiles

• 12.1 Anthrogenesis Corp.
  • 12.1.1 Anthrogenesis Corp. Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Cell therapy Processing Introduction
  • 12.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2014-2019)
  • 12.1.5 Anthrogenesis Corp. Recent Development
• 12.2 BioNTech
  • 12.2.1 BioNTech Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Cell therapy Processing Introduction
  • 12.2.4 BioNTech Revenue in Cell therapy Processing Business (2014-2019)
  • 12.2.5 BioNTech Recent Development
• 12.3 Cell Ideas
  • 12.3.1 Cell Ideas Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Cell therapy Processing Introduction
  • 12.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2014-2019)
  • 12.3.5 Cell Ideas Recent Development
• 12.4 Epic Sciences
  • 12.4.1 Epic Sciences Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Cell therapy Processing Introduction
  • 12.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2014-2019)
  • 12.4.5 Epic Sciences Recent Development
• 12.5 Roche
  • 12.5.1 Roche Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Cell therapy Processing Introduction
  • 12.5.4 Roche Revenue in Cell therapy Processing Business (2014-2019)
  • 12.5.5 Roche Recent Development
• 12.6 FuGENE
  • 12.6.1 FuGENE Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Cell therapy Processing Introduction
  • 12.6.4 FuGENE Revenue in Cell therapy Processing Business (2014-2019)
  • 12.6.5 FuGENE Recent Development
• 12.7 IBC Pharmaceuticals Inc.
  • 12.7.1 IBC Pharmaceuticals Inc. Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Cell therapy Processing Introduction
  • 12.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2014-2019)
  • 12.7.5 IBC Pharmaceuticals Inc. Recent Development
• 12.8 Bluebird Bio Inc.
  • 12.8.1 Bluebird Bio Inc. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Cell therapy Processing Introduction
  • 12.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2014-2019)
  • 12.8.5 Bluebird Bio Inc. Recent Development
• 12.9 Immodulon-Therapeutics
  • 12.9.1 Immodulon-Therapeutics Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Cell therapy Processing Introduction
  • 12.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2014-2019)
  • 12.9.5 Immodulon-Therapeutics Recent Development
• 12.10 Immunomedics Inc.
  • 12.10.1 Immunomedics Inc. Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Cell therapy Processing Introduction
  • 12.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2014-2019)
  • 12.10.5 Immunomedics Inc. Recent Development
• 12.11 Juno Therapeutics Inc.
• 12.12 Medlmmune Inc.
• 12.13 NeoStem Oncology
• 12.14 Neurotech USA
• 12.15 Novartis
• 12.16 Persimmune Inc.
• 12.17 Pluristem Therapeutics
• 12.18 BioMed Valley Discoveries Inc.
• 12.19 Regeneron Pharmaceuticals Inc.
• 12.20 UCL Business PLC.

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer